A recent analysis of adverse drug reactions by Indian Pharmacopoeia Commission revealed that combinations of beta-blockers ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

New international consensus guidelines were developed through a research method, known as a Delphi process, that used a ...

National DRESS Syndrome Day 2025 Highlights "Faces of DRESS" to Advocate for Urgent Scientific Investment RICHMOND, Va., July 2, 2025 /PRNewswire/ -- In ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

Benlysta is the first and only approved autoinjector biologic for both systemic lupus erythematosus and lupus nephritis ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

Chia seeds vs. Flaxseeds: Which superfood is truly better for you?